← SynDRA
ETHAVERINE
SynDRA canonical compound SYN0025542 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Mechanism of action | calcium channel blocker |
| Indication | muscle relaxant | spasms |
| Disease area | neurology/psychiatry |
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- DRD1
- ADRA1A
- ADORA3
- CHRM1
- PDE3A
- PDE4A
- PDE4D
- ESR1
- ACHE
- MAPK1
- OPRM1
- PGR
- PTGS1
- POLK
- LMNA
- SLC6A2
- SLC6A3
- SLC6A4
- SMN1
- TBXA2R
- TDP1
- TSHR
- MAOA
- HTR2B
- KDR
- KCNH2
- ADRA2A
- ALOX15B
- AR
- CHRM2
- CYP1A2
- CYP2C19
- CYP2C9
- CYP2D6
- CYP3A4
- DRD3
- F2
- GLP1R
- HDAC6
- HRH3
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ACES
- ANDR
- SMAD3
- SMAD2
- PRGR
- NSD2
- NR1I2
- MDR1
- KSYK
- IFNG
- GPR32
- GLI3
- ESRRA
- ESR2
- CREB1
- CP3A7
- CP3A4
- CP2D6
- CP2CJ
- CP2C9
- CP1A2
- SYK
Drug classes
- Parasympatholytics
- Peripheral Nervous System Agents
Cross-references
Synonyms
- ethquinol
- barbonin
- barbonine
- dyscural
- ethylpapaverine
- ethaverine hydrochloride
- ethaverine HCl
- Etaverina
- Ethquinol
- Ethylpapaverine
- 1-[(3,4-diethoxyphenyl)methyl]-6,7-diethoxyisoquinoline
- Ethaverinum
- 1-(3,4-Diethoxybenzyl)-6,7-diethoxyisoquinoline
- 6,7-Diethoxy-1-(3,4-diethoxybenzyl)isoquinoline
- 2H2HC19DYZ
- 1-((3,4-diethoxyphenyl)methyl)-6,7-diethoxyisoquinoline
- RefChem:138373
- DTXCID903009
- Barbonin
- Barbonine
- Dyscural
- Perparine
- Perperine
- Ethaverine [INN]
- Isoquinoline, 6,7-diethoxy-1-(3,4-diethoxybenzyl)-
- ISOQUINOLINE, 1-(3,4-DIETHOXYBENZYL)-6,7-DIETHOXY-
- 6,7-Diaethoxy-1-(3,4-diaethoxybenzyl)isochinolin
- Ethaverine (INN)
- 1-[(3,4-diethoxyphenyl)methyl]-6,7-diethoxy-isoquinoline
- Isoquinoline, 1-((3,4-diethoxyphenyl)methyl)-6,7-diethoxy-
- Isoquinoline, 1-[(3,4-diethoxyphenyl)methyl]-6,7-diethoxy-
- Etaverina [INN-Spanish]
- Ethaverinum [INN-Latin]
- ETHYLPAPAVERINE HYDROCHLORIDE
- NCGC00016557-01
- CAS-985-13-7
- EINECS 207-633-3
- UNII-2H2HC19DYZ
Look up ETHAVERINE in the interactive SynDRA portal →